Search Results 921-930 of 18582 for hepatitis

1. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

   ... hepatitis B surface antigen positivity, or hepatitis C with measurable viral titer. NOTE: Patients with antibody to hepatitis B core antibody are eligible ...

2. Study of BIIB092 in Participants With Progressive Supranuclear Palsy - Mayo Clinic

   Any other sound medical, psychiatric, and/or social reason as determined by the Investigator. Current hepatitis C or hepatitis B infection. Current hepatitis ...

3. Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   * Active hepatitis due to hepatitis B virus or hepatitis C virus * Known history or presence of venous thromboembolism/venous thrombotic events (deep vein ...

4. Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma - Mayo Clinic Research

   Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration · Rab GTPases As Drivers of Lipid Droplet ...

5. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

   Patients who are HBsAg negative and hepatitis B core antibody positive with no detectable hepatitis B virus (HBV) DNA will be allowed into the study but will ...

6. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

   ... hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low viral hepatitis titer on antivirals is allowed. Known significant mental illness ...

7. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

   ... hepatitis B surface antibody [HBsAb] positive, and hepatitis B core antibody [HBcAb] negative are eligible for the study);; Patients with positive HBcAb are ...

8. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   Positive hepatitis B (hepatitis B surface antigen and antibody) and/or hepatitis C (hepatitis C antibody test) as indicated by serologies conducted =< 3 ...

9. A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD) - Mayo Clinic

   Hepatitis C (defined as positive hepatitis C [HCV] antibody with positive HCV ribonucleic acid [RNA]). 8. Diagnosed with another malignancy (other than ...

10. A Study to Evaluate Hepatotoxicity Risk Associated with TURALIO™ (pexidartinib) Treatment - Mayo Clinic

    ... hepatitis A infection):. AST or ALT > 3 × ULN with concurrent total bilirubin > 2 × ULN;; Isolated total bilirubin > 2 × ULN (excluding patients with ...